With 5-7% of Women world wide experiencing Pre-eclampsia a definative test would become the de facto "gold standard" for screening ALL PREGNANT WOMEN. That's a lot of tests each year and such a test would be worth hundreds of milllions / year to Alere. What would MOM's cut be? Even if it were just 5% it would make us a $5.00-$10.00 stock. Why are we trading at $.10?